These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16796787)

  • 1. Clinical utility of gene microarray for the management of colorectal cancer.
    D'Orazio A
    Clin Colorectal Cancer; 2006 May; 6(1):25-8. PubMed ID: 16796787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metastasis-associated genes in colorectal cancer].
    Murata K; Inoue M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():102-6. PubMed ID: 14574864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mining microarray gene expression data of metastatic colorectal cancer by literature profiling].
    Huang ZX; Sun Q; Ding YQ; Yao KT
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1195-7. PubMed ID: 14625187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.
    Hao JM; Chen JZ; Sui HM; Si-Ma XQ; Li GQ; Liu C; Li JL; Ding YQ; Li JM
    J Pathol; 2010 Mar; 220(4):475-89. PubMed ID: 20077526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.
    Iwatsuki M; Mimori K; Yokobori T; Tanaka F; Tahara K; Inoue H; Baba H; Mori M
    J Surg Oncol; 2009 Sep; 100(3):261-6. PubMed ID: 19330779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in gene expression profile between high and low metastatic human colorectal cancer cell lines].
    Weng DS; Ding YQ; Sun Q
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):256-9. PubMed ID: 15041535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of TROP2 expression in colorectal cancer.
    Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
    Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Of what value genomics in colorectal cancer? Opportunities and challenges.
    Johnston PG
    J Clin Oncol; 2004 May; 22(9):1538-9. PubMed ID: 15051754
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies for treatment of KRAS mutant metastatic colorectal cancer.
    Prenen H; Tejpar S; Van Cutsem E
    Clin Cancer Res; 2010 Jun; 16(11):2921-6. PubMed ID: 20460490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of laparoscopic resection on expressions of metastasis genes in colorectal cancer: report of microarray analysis and literature review.
    Li J; Wang JW; Zheng S; Zhang SZ; Ding KF
    Hepatogastroenterology; 2011; 58(112):1975-82. PubMed ID: 22024071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
    Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
    Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.
    Ozawa H; Iwatsuki M; Mimori K; Sato T; Johansson F; Toh H; Watanabe M; Mori M
    Ann Surg Oncol; 2010 Sep; 17(9):2341-8. PubMed ID: 20339950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide microarray expression profiling of contrasting invasive phenotypes in colorectal cancer.
    Thorn CC; Williams D; Freeman TC
    Methods Mol Biol; 2011; 755():203-21. PubMed ID: 21761306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of trypsin and cancer proliferation in colorectal neoplasms].
    Yamamoto H; Nosho K; Taniguchi H; Imai K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():220-4. PubMed ID: 14574885
    [No Abstract]   [Full Text] [Related]  

  • 17. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
    Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
    Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
    Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
    Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategy study on colorectal cancer liver metastasis].
    Zheng S
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1948-9. PubMed ID: 17923028
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
    Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI
    Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.